A Phase I/Ib Study of NIZ985 in Combination With PDR001 in Adults With Metastatic Cancers

Clinical trial NCT02452268 · TERMINATED

Trial details

NCT number: NCT02452268
Sponsor: Novartis Pharmaceuticals
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Metastatic and Advanced Solid Tumors

Start date: 2017-05-08
Primary completion: 2022-03-07
Enrollment: 83

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.